The story of copyright's flagship drug presents a complex case for investors in the medicinal sector. While initially a phenomenal success, generating huge profits, the exclusivity end and the subsequent flood of https://knockoff304102.ja-blog.com/42079586/viagra-and-the-pharmaceutical-industry-a-hazardous-bet